Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
| Lot / Report | Tested | Purity | Lab | Panels | Status | |
|---|---|---|---|---|---|---|
| BPC-500-MH-02 | Mar 2026 | — | Vanguard Laboratory | Heavy metals | Unverified | View |
| KPC-001-MH-01 | Mar 2026 | — | Vanguard Laboratory | Heavy metals |
The FDA PCAC advisory committee meets July 23–24, 2026 to review nominations and make recommendations on compounding eligibility — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. BPC-157 is on the proposed list. If the FDA subsequently issues a final rule, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Disclosed Labs does not provide medical or legal advice.
Does Mile High Compounds sell BPC-157?
Mile High Compounds has 4 COAs on file for BPC-157 but no active price listing is currently tracked.
Is Mile High Compounds's BPC-157 third-party tested?
Yes — Disclosed Labs has indexed 4 Certificates of Analysis for Mile High Compounds's BPC-157, with the most recent showing 99.8% purity. Mile High Compounds holds an overall trust grade of B (85/100) across all 64 COAs on file.
What is Mile High Compounds's trust grade for BPC-157?
Mile High Compounds has an overall Disclosed Labs trust grade of B (85/100), computed from 64 COAs across all peptides. The most recent BPC-157 COA was issued by Vanguard Laboratory.
Where is the cheapest BPC-157?
As of the latest data, Alpha Peptides offers BPC-157 at $1.82/mg — compare with Mile High Compounds's listing. See the full BPC-157 price comparison.
Is BPC-157 legal to buy?
BPC-157 is among the peptides under FDA review for the Category 1 (503A) bulk-substances list — removed from Category 2 in April 2026 but not yet on a finalized Category 1 list. The FDA PCAC committee meets July 23–24, 2026 to make recommendations on which peptides may be compounded, and under what conditions — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. If a final rule is ultimately issued, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Current sales are for research purposes only. Disclosed Labs does not provide medical or legal advice.
| Unverified |
| View |
| BPC-010-MH-03 | Dec 2025 | 99.8% | Vanguard Laboratory | Endotoxin, Sterility, Heavy metals | Unverified | View |
| BPC-010-MH-02 | Aug 2025 | 99.1% | Chromate | — | Confirmed | View |